Breaking the Cold Chain for Vaccines

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2021
Volume 2021 eBook
Issue 2
Pages: 18–24

Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines.

Breaking the Cold Chain for Vaccines

Vaccine doses are often wasted due to challenges in maintaining cold storage from the manufacturing site to the patient. Aseptic spray drying offers a technology alternative to manufacture thermally stable vaccines, which can help ensure the stability and effectiveness of vaccines, extend shelf life, and reduce the potential for waste of these crucial products.

Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.

About the author

Sam de Costa is stabilization projects manager, Nova Laboratories Limited.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 18–24

Citation

When referring to this article, please cite it as S. de Costa, “Breaking the Cold Chain for Vaccines," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content